Literature DB >> 8509177

An economic analysis of liver transplantation. Costs, insurance coverage, and reimbursement.

R W Evans1, D L Manninen, F B Dong.   

Abstract

Liver transplantation is an expensive surgical procedure. In 1988, the median procedure charge was $145,795. Charges varied according to numerous prognostic variables. Insurance reimbursement often fell short of billed charges. Nonetheless, relative to other medical and surgical procedures, liver transplantation is cost-effective.

Mesh：

Year:  1993        PMID： 8509177

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  13 in total

1.  Temporal trends in early clinical outcomes and health care resource utilization for liver transplantation in the United States.

Authors:  John E Scarborough; Ricardo Pietrobon; Carlos E Marroquin; Janet E Tuttle-Newhall; Paul C Kuo; Bradley H Collins; Dev M Desai; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2007-01       Impact factor: 3.452

2.  A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease.

Authors:  P Ricci; T M Therneau; M Malinchoc; J T Benson; J L Petz; G B Klintmalm; J S Crippin; R H Wiesner; J L Steers; J Rakela; T E Starzl; E R Dickson
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

3.  Liver transplants and the decline in deaths from liver disease.

Authors:  R W Evans
Journal:  Am J Public Health       Date:  1997-05       Impact factor: 9.308

Review 4.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

5.  A cost analysis of alprostadil in liver transplantation.

Authors:  D G Smith; K S Henley; C S Remmert; S L Hass; I D McLaren
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

Review 6.  The human and economic cost of paracetamol (acetaminophen) overdose.

Authors:  G R Bond; J E Novak
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

7.  Predicting outcomes after liver transplantation. A connectionist approach.

Authors:  H R Doyle; I Dvorchik; S Mitchell; I R Marino; F H Ebert; J McMichael; J J Fung
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

8.  Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization.

Authors:  W R Kim; R H Wiesner; J J Poterucha; T M Therneau; M Malinchoc; J T Benson; J S Crippin; G B Klintmalm; J Rakela; T E Starzl; R A Krom; R W Evans; E R Dickson
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

9.  Cost-effectiveness and population outcomes of general population screening for hepatitis C.

Authors:  Phillip O Coffin; John D Scott; Matthew R Golden; Sean D Sullivan
Journal:  Clin Infect Dis       Date:  2012-03-12       Impact factor: 9.079

10.  Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis.

Authors:  Arun P Palanisamy; D J Taber; A G Sutter; S N Nadig; J E Dowden; J W McGillicuddy; P K Baliga; K D Chavin
Journal:  J Gastrointest Surg       Date:  2014-10-16       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.